Mike Sapieha
Chief Scientific Officer at UNITY Biotechnology and Professor at Unversity of Montreal
As the Wolfe Professor of Translational Research at the University of Montreal and director of the neurovascular eye disease research unit at Hôpital Maisonneuve-Rosemont in Montreal, Mike has made seminal contributions to the understanding of ophthalmologic diseases. His pioneering work in the biology of eye diseases has been widely recognized, and he is recipient of the Alcon Research Institute Senior Investigator Award and the Cogan Award in Vision Research. He was a postdoctoral fellow at Harvard Medical School and McGill University, where he worked on the patho-mechanisms of retinopathy of prematurity and the roles of metabolism and lipids in this disease. Mike obtained a Ph.D. and M.Sc. in pathology and cellular biology at University of Montreal.
Visit website: https://unitybiotechnology.com/about/
mike-przemyslaw-sapieha-65256028
See also: UNITY Biotechnology - Biotechnology company devoted to research of restoring human health
Details last updated 20-Oct-2024
Mike Sapieha is also referenced in the following:
The Longevity Summit 2024
03-Dec-2024 to 04-Dec-2024
Longevity researchers, investors, and entrepreneurs speaking about eliminating disease of ageing by Longevity Global (Novato, CA, USA)